Figure 7.

Separation of ER^- and ER⁺ breast cancer samples. According to the immunoblotting classification, our method has two misclassified samples, namely 14 and 31. However, both samples are placed at the furthest end of the ER⁺ cluster and are joined in a single branch, possibly indicating an intermediate disease stage.